UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		20,027,065
Beginning balance at Dec. 31, 2022	$ 63,306	$ 20	$ 733,437	$ (670,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation costs	608		608
5-Year Private Warrants transferred to 5-Year Public Warrants	531		531
Net loss	(13,909)			(13,909)
Ending balance (in shares) at Mar. 31, 2023		20,027,065
Ending balance at Mar. 31, 2023	50,536	$ 20	734,576	(684,060)
Beginning balance (in shares) at Dec. 31, 2022		20,027,065
Beginning balance at Dec. 31, 2022	63,306	$ 20	733,437	(670,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(27,798)
Ending balance (in shares) at Jun. 30, 2023		20,195,401
Ending balance at Jun. 30, 2023	37,614	$ 20	735,543	(697,949)
Beginning balance (in shares) at Mar. 31, 2023		20,027,065
Beginning balance at Mar. 31, 2023	50,536	$ 20	734,576	(684,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation costs	952		952
5-Year Private Warrants transferred to 5-Year Public Warrants	15		15
Vesting of restricted stock units (in shares)		168,336
Vesting of restricted stock units	0		0
Net loss	(13,889)			(13,889)
Ending balance (in shares) at Jun. 30, 2023		20,195,401
Ending balance at Jun. 30, 2023	37,614	$ 20	735,543	(697,949)
Beginning balance (in shares) at Dec. 31, 2023		20,736,612
Beginning balance at Dec. 31, 2023	12,656	$ 21	737,810	(725,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants (in shares)		517,688
Issuance of common stock and warrants	1,160		1,160
Stock-based compensation costs	678		678
Vesting of restricted stock units (in shares)		2,595
Net loss	(20,749)			(20,749)
Ending balance (in shares) at Mar. 31, 2024		21,256,895
Ending balance at Mar. 31, 2024	(6,255)	$ 21	739,648	(745,924)
Beginning balance (in shares) at Dec. 31, 2023		20,736,612
Beginning balance at Dec. 31, 2023	12,656	$ 21	737,810	(725,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(33,930)
Ending balance (in shares) at Jun. 30, 2024		24,022,151
Ending balance at Jun. 30, 2024	(9,731)	$ 21	749,352	(759,104)
Beginning balance (in shares) at Mar. 31, 2024		21,256,895
Beginning balance at Mar. 31, 2024	(6,255)	$ 21	739,648	(745,924)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants (in shares)		2,474,859
Issuance of common stock and warrants	8,898		8,898
Stock-based compensation costs	801		801
5-Year Private Warrants transferred to 5-Year Public Warrants	5		5
Vesting of restricted stock units (in shares)		290,397
Net loss	(13,180)			(13,180)
Ending balance (in shares) at Jun. 30, 2024		24,022,151
Ending balance at Jun. 30, 2024	$ (9,731)	$ 21	$ 749,352	$ (759,104)